Literature DB >> 33019883

The Potential for Telemedicine to Reduce Bias in Patients Seeking Facial Plastic Surgery.

Parsa P Salehi1, Brian J F Wong2, Babak Azizzadeh3,4.   

Abstract

Telemedicine use among otolaryngologists-head and neck surgeons and facial plastic and reconstructive surgeons has accelerated as a result of the COVID-19 pandemic. Yet, it is unclear what impact the increased adoption of telehealth will have on the doctor-patient relationship, patients' perceptions of individual practices, and the likelihood of patients proceeding with the next steps toward surgery. While an understanding of these complex questions is imperative for all otolaryngologists, it is extremely important for facial plastic surgeons who focus on elective procedures, particularly cosmetic/aesthetic operations. The use of telemedicine has the potential to reduce bias among patients seeking facial plastic surgery, especially cosmetic procedures. As reports of this phenomenon are anecdotal thus far, we recommend further study into the specific criteria that patients consider when selecting a facial plastic surgeon.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; bias; choosing surgeon; coronavirus; pandemic; patient bias; public health; surgeon selection; telehealth; telemedicine; virus

Year:  2020        PMID: 33019883     DOI: 10.1177/0194599820964731

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Reflecting on Plastic Surgery Training During Early COVID-19 Pandemic: Resident Exposure and Telemedicine.

Authors:  Anabel Epstein; Sinan Kallo Jabori; Luccie M Wo; Melissa Huberman; Georges Samaha; Steven Ovadia; Seth R Thaller
Journal:  J Craniofac Surg       Date:  2022-06-28       Impact factor: 1.172

2.  Plastic Surgeons Nationwide Share Experience Regarding Telemedicine in Initial Patient Screening and Routine Postoperative Visits.

Authors:  Thais Calderon; Kathryn E H Skibba; Howard N Langstein
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.